|
Wednesday August 06, 2008 The health insurance has just revealed that in 2007, the French increased their consumption of medicines. She values the expenses of repayment to more of 21 billions of euros, either a rise of 4,6% in relation to the previous year. According to the social Security, the reasons of this increase are: the new products appeared on the market, that knows a very fast progression. These molecules, more recent and dearer, substitute themselves for the "less expensive medicines to comparable efficiency"; the medicines used in the treatment of the heavy pathologies as the cancers or the AIDS, that are expensive and represent very sold products; the repayment in the setting of a hold in charge to 100%. " 45% of the expenses concern some medicines took in charge to 100%, essentially to the title of a long length" affection. Here is that explains the will of the leader of the National union of the health insurance Cases maybe to want to lower the percentage of this hold in charge in the beginning of the summer 2008. An idea that had caused quick polémiues then.
Of one point of more quantitative view, the family of the analgesics is the most prescribed (380 millions of boxes repaid), consistent of the psycholeptiques (109 millions of boxes) and of the antibiotics (89 millions of boxes).
In the order, the 10 medicines most prescribed and repaid in France for 2007 are: Doliprane (88 505 000 prescribed units) Efferalgan (42 910 000 prescribed units) Dafalgan (41 031 000 prescribed units) Levothyrox (19 386 000 prescribed units) Kardegic (17 126 000 prescribed units) Spasfon (14 785 000 prescribed units) Tahor (11 629 000 prescribed units) Voltarène (11 546 000 prescribed units) Methadone CHL APHP (11 201 000 prescribed units) Eludril (10 852 000 prescribed units)
|
